Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15708 Pomerado Rd Ste 103
Poway, CA 92064Phone+1 858-674-1289Fax+1 858-726-6221
Education & Training
UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2000 - 2005- University of California (San Diego) Medical CenterFellowship, Geriatric and Cognitive Neurology, 1998 - 2000
University of California (Irvine)Residency, Neurology, 1995 - 1998
University of Arizona College of Medicine-TucsonInternship, Internal Medicine, 1994 - 1995
University of Missouri Kansas City School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 Start of enrollment: 2009 Jul 01
- A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) Start of enrollment: 2017 Mar 23
- Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsEffects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.Pazit Bar-On, Edward Rockenstein, Anthony Adame, Gilbert Ho, Makoto Hashimoto
Journal of Neurochemistry. 2006-08-01 - 706 citationsA phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H. Tuszynski, Leon J. Thal, Mary Pay, David P. Salmon, Hoi Sang U
Nature Medicine. 2005-04-24 - 28 citationsImportance of adiponectin activity in the pathogenesis of Alzheimer's diseaseMasaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Kazunari Sekiyama, Shuei Sugama
Annals of Clinical and Translational Neurology. 2017-07-11
Journal Articles
- A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H Tuszynski, Leon Thal, Mary Pay, David P Salmon, Hoi Sang U, Roy Bakay, Piyush Patel, Armin Blesch, H Lee Vahlsing, Gilbert Ho, Gang Tong, Steven G Potkin, James..., Nature Medicine, 4/24/2005
Professional Memberships
- Member
- Society for NeuroscienceMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
